Ambuja Cements Q2 FY27: Can margin resilience offset demand softness?
Ambuja enters Q2 FY27 with elevated capacity and operational leverage, but bearish price action and soft demand flows signal a quarter where execution on volumes and cost control will matter more than hopes.
The Setup: Capacity vs Demand
Ambuja Cements enters Q2 FY27 at an inflection point. On one side: the company has just commissioned new grinding capacity (1.2 MTPA at Dahej) and subsidiary expansions, bringing consolidated capacity to 113.45 MTPA—a structural boost to potential output. On the other: Q1 FY27 revealed the harder truth. Revenue from operations fell 7.7% year-on-year to ₹9,474 Cr, and consolidated PAT plummeted 32% to ₹660 Cr. Margins compressed. The Street is watching whether Q2 can stabilise the print or whether sector-wide demand softness and competitive intensity will persist.
~₹9,200–9,500 Cr
In line with Q1 run-rate (₹9,474 Cr); modest growth if demand inflects, flat if sector remains soft
~16.5–17.0 MnT
Trade volume target remains ~78% of capacity; track record shows 16.6 MnT in prior comparable quarter
~17–19%
Q1 margin was unspecified; prior quarter peak was 19.2%. Swing driver: input costs (coal, power) and pricing power
₹700–850 Cr
Recovery from Q1's ₹660 Cr contingent on EBITDA stabilisation and tax rate. Downside if volumes or spreads disappoint
A strong quarter would see volume hold at or above 16.7 MnT, EBITDA margins recover toward 18.5%+, and PAT expand into the ₹800–900 Cr band—signalling that the post-GST demand bump is translating into cash. A weak quarter would repeat Q1's pattern: flat-to-negative revenue growth, margin compression below 17%, and PAT in the ₹600–700 Cr range, suggesting that structural softness in the sector is overriding the company's operational gains.
On Track with Full-Year Guidance?
Ambuja has not yet formally issued explicit FY27 revenue or PAT guidance that we can track. However, the framing from management and the capacity roadmap offer clues. The company is targeting 119 MTPA capacity by FY27-end (further expansions beyond the current 113.45 MTPA). At a 78% trade-share run-rate, that implies ~93 MnT full-year sales—a 6–8% organic growth from FY26 baseload. On that trajectory, a flat-to-modest revenue growth in H1 (which Q1 delivered) would need to accelerate in H2 to hit the target. Whether Q2 shows the first signs of that re-acceleration—or a deteriorating run-rate—will reset expectations.
Since Last Quarter: What's Changed
1 · Capacity Commissioning (Sep 30, 2026)
Ambuja and subsidiaries ACC and Adani Cement Industries completed expansion projects, lifting consolidated capacity to 113.45 MTPA. This is not routine—it represents the structural inflection the Street has been pricing. Capex efficiency ($ 48/MT for debottlenecking) is also notable.
2 · Merger Scheme Approvals (Aug–Sep 2026)
NCLT orders issued for ACC merger (Sep 29) and Orient Cement amalgamation (Jul 20). Two shareholder meetings scheduled; these are pre-closing. Regulatory de-risking is progressing. Post-merger, consolidated capacity and operational leverage will add a third dimension to earnings—not yet in the print.
3 · FII Stake Erosion
Foreign institutional ownership dropped from 5.87% (Q1 FY27) to 5.63%, the lowest in the dataset. Domestic institutions stable at 19.64%. Promoters unchanged at 67.33%. The FII outflow may signal repositioning ahead of Q2, or a broader sector de-rating.
4 · Trading Window Closure (Sep 28, 2026)
Board closed the trading window for Q3 FY27 results. Routine housekeeping; no insider activity flagged.
The Watch List for Result Day
1 · Volume: Did trade-share hold at 78%?
If Ambuja maintains 16.5+ MnT volumes in Q2, it suggests the new capacity is ramping and demand isn't collapsing. Below 16 MnT would imply sector softness is eating into share. This is the baseline.
2 · Margin spread: EBITDA and PAT clarity
Input costs (coal, power) and cement pricing are the swing factors. A margin recovery into the 18–19% band (vs. an assumed ~16–17% in Q1) would validate that Ambuja's cost discipline and product mix (premium products at 76% of trade) are cushioning sector headwinds. Compression below 16% would be a red flag.
3 · FY27 full-year reset
Management commentary on H2 demand, the merger accretion timeline, and FY28 capacity ramp will matter more than Q2 alone. If guidance is raised or reaffirmed with confidence, it counters the stock's bearish re-rating. If it's cautious or cut, the narrative shifts to waiting for FY28 recovery.
The Bottom Line
Ambuja Cements reports Q2 FY27 on October 29 with the structure in place for upside but the demand environment and stock momentum working against near-term optimism. The company has just commissioned 113.45 MTPA in consolidated capacity and is on the cusp of merger closures that will add another operational lever. But Q1's 32% PAT decline and the stock's 48% retreat from ATH signal that the Street is pricing in a transitional period where capacity ramps faster than demand can absorb it.
What a strong print would look like: revenue near ₹9,500 Cr, volumes at or above 16.7 MnT, EBITDA margin holding at 18%+, and PAT of ₹800 Cr+. That would put the trajectory on pace for FY27 full-year growth and justify the capacity capex. A weak print repeats Q1: flat-to-down revenue, sub-17% margin, and PAT in the ₹600–700 Cr band—signalling that the sector headwinds are structural and the capacity boost will take time to translate.
Watch volume, monitor margin resilience, and listen for management's confidence on H2 demand. The Street consensus is constructive, but the price action and FII selling suggest conviction is fragile. Result day will reset the bar.
Ambuja Cements Q2 FY27: consolidated PAT ₹236 Cr, down 90% YoY on fading tax credit
PAT -89.9% YoY · revenue +0.4% · margins compressing · miss vs street
₹9,166 Cr
+0.4% YoY
₹236 Cr
-89.9% YoY
2.55%
-21.9pp YoY
₹0.78
Ambuja Cements' consolidated PAT for Q2 FY27 (quarter ended September 30, 2026) came in at ₹236 Cr, down 89.9% YoY from a restated ₹2,336 Cr and down 64.2% QoQ from ₹660 Cr, against revenue that was essentially flat YoY at ₹9,166 Cr (+0.4%) but down 3.3% QoQ from ₹9,474 Cr. Standalone told the same story (PAT ₹114 Cr, down ~90% YoY). This is well short of what we flagged pre-result: our preview's on-plan band was revenue ₹9,200–9,500 Cr (actual landed just below it) and PAT ₹700–850 Cr (actual missed by roughly two-thirds) — a clear miss on the Street-anchored expectation we set out, and we found no fresh third-party consensus specifically for this quarter published yet to cross-check against.
Q2 FY-2027 vs prior quarters
The headline YoY drop is largely a base effect, not purely an operating collapse: Q2 FY26's reported PAT was inflated by a one-off ₹1,710 Cr tax-provision write-back (favourable High Court rulings freed legacy provisions at the standalone entity and at ACC), producing a net tax credit of ₹1,453 Cr that quarter versus a routine ₹62 Cr tax charge this quarter. Stripping that one-off and this quarter's/last year's exceptional items (₹85 Cr VSS cost now vs ₹223 Cr West Bengal incentive write-off a year ago) still leaves adjusted PAT down roughly 62% YoY (~₹321 Cr vs ~₹849 Cr) — core, pre-exceptional pretax profit fell from ₹1,102 Cr to ₹378 Cr YoY and from ₹867 Cr to ₹378 Cr QoQ, implying an EBITDA margin near 14.5% of revenue, below the 17–19% band we were watching. Total expenses rose 6.6% YoY to ₹8,877 Cr against flat revenue, led by power & fuel (+8.5% YoY to ₹2,552 Cr) and freight (+5.7% YoY to ₹2,180 Cr) — the squeeze sits on the cost line, not topline weakness.
The stock went into the print at ₹354.85, down 5.2% over the past month of trading.
Maintain 8% FY27 volume growth targeting 80MT; cost per ton to reach ₹4,250 by year-end (Q1 at ₹4,241); capex ₹6,000–6,500 Cr on track (~₹1,600 Cr spent Q1). New capacity (10.2 MT) commissioned by FY27-end, lifting installed to 119 MT.
Management's Q1 FY27 guidance (8% FY27 volume growth to 80 MT, cost/tonne to ₹4,250 by year-end from ₹4,241 in Q1, capex ₹6,000–6,500 Cr, capacity to 119 MT) cannot be verified against this filing — it contains only the regulatory financial statements and notes, with no MD&A, investor presentation or management quote, so volume and cost-per-tonne for the quarter are simply not disclosed here. What the filing does show: H1 FY27 capex spend of ₹2,967 Cr (consolidated) is tracking within the ₹6,000–6,500 Cr full-year band, and our event records put consolidated capacity at 113.45 MTPA as of September 30, 2026, progressing toward the 119 MT FY27-end target. The Board also approved acquiring 26% of SWE Renewables Ltd for ~₹33.75 Cr to secure captive wind power — a direct lever against the power-cost pressure visible in this quarter's expense line — and a further ₹85 Cr exceptional VSS charge (after ₹24 Cr in Q1) continues to flow from the voluntary-severance/plant-suspension exercise started last quarter.
W1
Cost-per-tonne trajectory toward management's ₹4,250/tonne FY27 target (₹4,241 in Q1 FY27) — not disclosed in this filing, to verify via investor presentation/concall.
W2
Further exceptional charges or resolution of the Voluntary Severance Scheme/plant-suspension restructuring (₹85 Cr this quarter, ₹109 Cr for H1 FY27).
W3
FY27 volume growth pace toward the 80 MT / 8% target and capacity ramp to 119 MT, alongside the SWE Renewables captive-power integration.
Clean digital filing, both statements fully legible; totalIncome also includes govt grants (std ₹8 Cr, consol ₹31 Cr) not shown separately above. Consolidated PBT includes +₹5 Cr JV/associate share. Year-ago comparator in this filing is restated (consol PAT ₹2,336 Cr / standalone PAT ₹1,158 Cr) per Note 3's Orient Cement PPA finalisation; our DB's pre-restatement figure was ₹2,302.28 Cr — YoY math below uses the filing's own restated comparator.